Site Map
Site Map of
http://www.researchandmarkets.com
-
Site Map
-
Pharmaceuticals and Healthcare
-
Pharmaceuticals 1
(
Latest Titles
)
Pharmaceuticals 2
Pharmaceuticals 3
Pharmaceuticals 4
-
Women's Health
<< You are in This Category
#
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
A
Abnormal Uterine Bleeding: An Evaluation of Professional Education Programs Among Global Endometrial Ablation Competitors
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: An Evaluation of Sales Reps Among Global Endometrial Ablation Competitors.
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: An Identification and Quantification of the Evaluation Criteria Used by Ob/Gyn Surgeons to Evaluate Global Endometrial Ablation Companies
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Analysis of the Ob/Gyn Market Dynamics and Future Trends Among Leading Global Endometrial Ablation Systems
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Applying the 80/20 Rule to AUB Procedures
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Assessing the Strengths of Associations Between GEA Brands and their Manufacturers
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Considerations that Shape Product Preferences in Obstetrics and Gynecology
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: How Competing GEA Companies are Positioned in the Minds of Ob/Gyn Surgeons
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: How do Ob/Gyn Surgeons Who Perform Global Endometrial Ablation Procedures Prefer to be Trained and Educated on New Products, Procedures and Methods?
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Importance, Performance and Relative Position; A Gap Analysis that Identifies Opportunities for GEA Manufacturers
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Patient Characteristics and Treatment Modalities Associated with AUB
static version
printer friendly
pdf version
Abnormal Uterine Bleeding: Trends in Procedures for the Treatment of AUB
static version
printer friendly
pdf version
^ Top
C
Commercial And Pipeline Insight: HRT For Menopausal Symptoms – A New Class Restores An Old Market
static version
printer friendly
pdf version
Commercial and Pipeline Insight: Infertility - Optimizing a market bounded by social opinion and physician preference
static version
printer friendly
pdf version
Commercial Insight: Osteoporosis and HRT - Novel Osteoporosis Drugs Counter Generic Threat While HRT Players Regroup and Move Forward
static version
printer friendly
pdf version
Contraception Market Report 2007
static version
printer friendly
pdf version
Contraceptive Devices: Gap Analysis - Opportunities and Threats in the Contraceptive Device Market
static version
printer friendly
pdf version
Contraceptive Devices: How is the Performance of Contraceptive Device Manufacturers Perceived by Ob/Gyn Surgeons?
static version
printer friendly
pdf version
Contraceptive Devices: Improving Birth Control Device Manufacturers, Sales Rep Performance
static version
printer friendly
pdf version
Contraceptive Devices: Improving Professional Education Events for Ob/Gyn’s Specializing in Birth Control Procedures
static version
printer friendly
pdf version
Contraceptive Devices: Improving the Efficiency of Training and Education Methods to Better Meet the Needs of Ob/Gyn Surgeons
static version
printer friendly
pdf version
Contraceptive Devices: Treatment Characteristics of Obstetrics and Gynecology Surgeons Specializing in Birth Control Procedures
static version
printer friendly
pdf version
Contraceptive Devices: Where Are They Now? Understanding Obstetrics & Gynecology Trends in the Use of Birth Control Devices
static version
printer friendly
pdf version
Contraceptives: Market Dynamics - Adoption, Switching and Cross Use Trends Among Ob/Gyn’s in the Birth Control Device Market
static version
printer friendly
pdf version
^ Top
D
Drugs of Tommorow 2002: Breast Cancer
static version
printer friendly
pdf version
^ Top
E
Endometriosis - Growing the Patient Population is Key to Unlocking the Markets Commercial Potential
static version
printer friendly
pdf version
Endometriosis Market, 2003-2011
static version
printer friendly
pdf version
^ Top
F
Female Sexual Dysfunction: Prescription Drug Pipeline Overview 2007
static version
printer friendly
pdf version
Funding for Womens Health Programs: How to Secure the Money Needed to Help Your Program Thrive, Live Audio-Conference on CD-ROM
static version
printer friendly
pdf version
^ Top
M
Major Milestones: Female Sexual Dysfunction
static version
printer friendly
pdf version
Mammography World Markets
static version
printer friendly
pdf version
^ Top
O
Obstetrics & Gynecology
static version
printer friendly
pdf version
Obstetrics and Gynecology – Improving your Competitive Position
static version
printer friendly
pdf version
Obstetrics and Gynecology: A Snapshot of the Ob/Gyn Surgery Market
static version
printer friendly
pdf version
Obstetrics and Gynecology: Customer Value Drivers – Understanding the Drivers that Determine Ob/Gyn’s Product Preferences
static version
printer friendly
pdf version
Obstetrics and Gynecology: The Customer Connection - How to Increase the Efficiency and Effectiveness of Sales Calls, Marketing and Professional Education
static version
printer friendly
pdf version
Obstetrics and Gynecology: The Opportunity Index – Capitalizing on Market Gaps
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: Assessing the Strength of Associations Between Brands and Their Manufacturer.
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: Evaluating the Effectiveness of Sales Reps in Obstetrics and Gynecology
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: How is the Performance of Oral Contraceptive Device and Hormone Therapy Manufacturers Perceived by Ob/Gyn Surgeons?
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: Improving the Efficiency of Training and Education Methods to Meet the Needs of Ob/Gyn Surgeons
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: Insights into the Positioning of Pharmaceutical Companies in the Obstetrics and Gynecology Market
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: Investigating the Dynamics of Brand Use - An Analysis of Switching, Exclusive Use and Future Trends in Obstetrics/Gynecology
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: Revealing Opportunities and Threats in Obstetrics and Gynecology Through Gap Analysis
static version
printer friendly
pdf version
Oral Contraception and Hormone Therapy: What Considerations Shape Preferences in Obstetrics and Gynecology?
static version
printer friendly
pdf version
Osteoporosis and Hormone Replacement Therapy Market, 2003-2011
static version
printer friendly
pdf version
Oxford Handbook of Obstetrics and Gynaecology, First Edition
static version
printer friendly
pdf version
^ Top
P
Partneringreview 2006: Biopharma Deal Making By Therapy Area - Genitourinary/Gynecology
static version
printer friendly
pdf version
Pipeline Insight: Hormone Replacement Therapy - Wyeth positions to strike back?
static version
printer friendly
pdf version
Pipeline Insight: Hormone Replacement Therapy - Wyeth positions to strike back?
static version
printer friendly
pdf version
Policing Pregnancy - the Law and Ethics of Obstetric Conflict
static version
printer friendly
pdf version
^ Top
S
Stakeholder Opinions: Gynecological Cancers - Niche Opportunities in Advanced Disease
static version
printer friendly
pdf version
Strategic Analysis of the U.S. Hypothermia Normothermia and Cold Therapy Markets
static version
printer friendly
pdf version
Strategic Perspective 2001: Female Cancers - Optimizing Market Opportunities
static version
printer friendly
pdf version
Strategic Perspectives 2001: Breast Cancer Cost Analysis
static version
printer friendly
pdf version
Strategic Perspectives 2001: Eating Disorders - Anorexia Nervosa and Bulimia Nervosa, New Indications For Leading Players
static version
printer friendly
pdf version
Strategic Perspectives 2001: Ovarian Cancer - Overview of Current and New Developments
static version
printer friendly
pdf version
Strategic Perspectives 2002: CNS Disorders in Women - Urinary Incontinence
static version
printer friendly
pdf version
^ Top
T
The Obstetrics/Gynecology Hormone & Contraceptive Market: Opportunities for Growth, Customer Retention & Increased Efficiency
static version
printer friendly
pdf version
The Women’s Health Market Outlook to 2011
static version
printer friendly
pdf version
The World Market for Gynaecology, 2007-2017
static version
printer friendly
pdf version
Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride
static version
printer friendly
pdf version
^ Top
W
Women’s Health Diagnostic Tests
static version
printer friendly
pdf version
Women’s Health Issues: Trends in Diagnosis & Treatment
static version
printer friendly
pdf version
Womens Health - Menopausal Symptoms Drug Pipeline Report
static version
printer friendly
pdf version
Womens Health Contraception
static version
printer friendly
pdf version
Womens Health Dysmenorrhea
static version
printer friendly
pdf version
Womens Health Endometriosis
static version
printer friendly
pdf version
Womens Health Female Sexual Dysfunction
static version
printer friendly
pdf version
Womens Health Infertility
static version
printer friendly
pdf version
Womens Health Labor and Delivery
static version
printer friendly
pdf version
Womens Health Menopausal Symptoms
static version
printer friendly
pdf version
Womens Health Postmenopausal Osteoporosis
static version
printer friendly
pdf version
Womens Health Vaginal Infections
static version
printer friendly
pdf version
Worldwide Prescription Drug Market for Womens Health: Now and Future 2004-2009
static version
printer friendly
pdf version
All rights reserved. © copyright 2006 Research and Markets
Terms and conditions
Privacy Policy